α1-antitrypsin deficiency alleles in cystic fibrosis lung disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 3 I, 2003, Pages 390-396

  Frangolias, Despina Daisy ^a   Ruan, Jian ^b   Wilcox, Pearce J ^b   Davidson, A George F ^b   Wong, Lawrence T K ^b   Berthiaume, Yves ^b   Hennessey, Rosamund ^b   Freitag, Andreas ^b   Pedder, Linda ^b   Corey, Mary ^b   Sweezey, Neil ^b   Zielenski, Julian ^b   Tullis, Elizabeth ^b   Sandford, Andrew J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ACUTE DISEASE; ADULT; ALLELE; ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; CANADA; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DEATH; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LUNG DISEASE; LUNG INFECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PROGNOSIS; PROTEIN DEFICIENCY; PSEUDOMONAS AERUGINOSA;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; ALLELES; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSEUDOMONAS AERUGINOSA; TIME FACTORS;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0041328745     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0271OC     Document Type: Article

References (33)

1. Cantin, A. M., S. Lafrenaye, and R. O. Begin. 1991. Antineutrophil elastase activity in cystic fibrosis serum. Pediatr. Pulmonol. 11:249-253.
2. Birrer, P., N. G. McElvaney, A. Rudeberg, C. W. Sommer, S. Liechti-Gallati, R. Kraemer, R. Hubbard, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213.
3. O'Connor, C. M., K. Gaffney, J. Keane, A. Southey, N. Byrne, S. O'Mahoney, and M. X. Fitzgerald. 1993. alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am. Rev. Respir. Dis. 148:1665-1670.
4. Goldstein, W., and G. Doring. 1986. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:49-56.
5. Plotkowski, M. C., G. Beck. J. M. Tournier, M. Bernardo-Filho, E. A. Marques, and E. Puchelle. 1989. Adherence of Pseudomonas aeruginosa to respiratory epithelium and the effect of leucocyte elastase. J. Med. Microbiol. 30:285-293.
6. Plotkowski, M. C., A. M. Saliba, S. H. Pereira, M. P. Cervante, and O. Bajolet-Laudinat. 1994. Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells. Infect. Immun. 62:5456-5463.
7. Hilman, B. C. 1997. Genetic and immunologic aspects of cystic fibrosis. Ann. Allergy Asthma Immunol. 79:379-390.
8. Brown, M. A., W. J. Morgan, P. R. Finley, and P. Scuderi. 1991. Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis. Pediatr. Pulmonol. 10:86-91.
9. Suter, S. 1986. Imbalance between polymorphonuclear leukocyte proteases and antiproteases in chronic pyogenic infections and its relation to the proteolysis of complement component C3. Complement 3:1-24.
10. Santis, G., L. Osborne, R. Knight, M. E. Hodson, and M. Ramsay. 1990. Genetic influences on pulmonary severity in cystic fibrosis. Lancet 335:294.
11. Santis, G., L. Osborne, R. Knight, M. Ramsay, R. Williamson, and M. Hodson. 1990. Cystic fibrosis haplotype association and the delta F508 mutation in adult British CF patients. Hum. Genet. 85:424-425.
12. Morgan, K., G. Scobie, P. Marsters, and N. A. Kalsheker. 1997. Mutation in an alpha1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors. Biochim. Biophys. Acta 1362:67-76.
13. Doring, G., H. Krogh-Johansen, S. Weidinger, and N. Hoiby. 1994. Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508. Pediatr. Pulmonol. 18:3-7.
14. Mahadeva, R., S. Stewart, D. Bilton, and D. A. Lomas. 1998. Alpha-1 anti-trypsin deficiency alleles and severe cystic fibrosis lung disease. Thorax 53:1022-1024.
15. Mahadeva, R., R. C. Westerbeek, D. J. Perry, J. U. Lovegrove, D. B. Whitehouse, N. R. Carroll, R. I. Ross-Russell, A. K. Webb, D. Bilton, and D. A. Lomas. 1998. Alpha-1 antitrypsin deficiency alleles and the Taq-I G→A allele in cystic fibrosis lung disease. Eur. Respir. J. 11:873-879.
16. Henry, M. T., S. Cave, J. Rendall, C. M. O'Connor, K. Morgan, M. X. FitzGerald, and N. Kalsheker. 2001. An alpha(1)-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis. Eur. J. Hum. Genet. 9:273-278.
17. Sandford, A. J., T. Chagani, J. J. Spinelli, and P. D. Pare. 1999. alphaI-antitrypsin genotypes and the acute-phase response to open heart surgery. Am. J. Respir. Crit. Care Med. 159:1624-1628.
18. Anonymous. 1995. Standardization of Spirometry, 1994 update. American Thoracic Society. Am. J. Respir. Crit. Care Med. 152:1107-11136.
19. Crapo, R. O., A. H. Morris, and R. M. Gardner. 1981. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 123:659-4564.
20. Hibbert, M. E., A. Lannigan, L. I. Landau, and P. D. Phelan. 1989. Lung function values from a longitudinal study of healthy children and adolescents. Pediatr. Pulmonol. 7:101-109.
21. Shwachman, H., and L. Kulczycki. 1958. Long-term study of one hundred five patients with cystic fibrosis. Am. J. Dis. Child. 96:6-15.
22. Brasfield, D., G. Hicks, S. Soong, and R. E. Tiller. 1979. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 63:24-29.
23. Kalsheker, N. A., G. L. Watkins, S. Hill, K. Morgan, R. A. Stockley, and R. B. Fick. 1990. Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis. Markers 8:151-157.
24. Seersholm, N., J. T. Wilcke, A. Kok-Jensen, and A. Dirksen. 2000. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ. Am. J. Respir. Crit. Care Med. 161:81-84.
25. McElvaney, N. G., R. C. Hubbard, P. Birrer, M. S. Chernick, D. B. Caplan. M. M. Frank, and R. G. Crystal. 1991. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet 337:392-394.
26. Voulgari, F., P. Cummins, T. I. Gardecki, N. J. Beeching, P. C. Stone, and J. Stuart. 1982. Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. Br. Heart J. 48:352-356.
27. Kueppers, F. 1968. Genetically determined differences in the response of alpha-antitrypsin levels in human serum to typhoid vaccine. Humangenetik 6:207-214.
28. Morlese, J. F., T. Forrester, and F. Jahoor. 1998. Acute-phase protein response to infection in severe malnutrition. Am. J. Physiol. 275:E112-E117.
29. Frangolias, D. D., C. L. Holloway, S. Vedal, and P. G. Wilcox. Role of exercise and lung function in predicting work status in cystic fibrosis. Am. J. Respir. Crit. Care Med. (In press)
30. Frangolias, D. D., and P. G. Wilcox. 2001. Predictability of oxygen desaturation during sleep in patients with cystic fibrosis: clinical, spirometric, and exercise parameters. Chest 119:434-441.
31. Quittner, A. L., and A. Buu. 2002. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr. Pulmonol. 33:269-276.
32. Goldbeck, L., and T. G. Schmitz. 2001. Comparison of three generic questionnaires measuring quality of life in adolescents and adults with cystic fibrosis: the 36-item short form health survey, the quality of life profile for chronic diseases, and the questions on life satisfaction. Qual. Life Res. 10:23-36.
33. Bradley, J., O. McAlister, and S. Elborn. 2001. Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur. Respir. J. 17:712-715.